Clinical Trials Browser

Interventional × Hepatitis C × elbasvir-grazoprevir drug combination × Clear all

NCT02940496 2025-07-15

Pembrolizumab (MK-3475) in Hepatocellular Carcinoma

Phase 2 Completed

15 enrolled 8 charts

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

NCT04546802 2020-09-14

HATCHeT

Phase 3 Withdrawn

Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular